RedHill Biopharma Ltd. (NASDAQ:RDHL) Short Interest Up 325.0% in November

RedHill Biopharma Ltd. (NASDAQ:RDHL) was the target of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 6,800 shares, an increase of 325.0% from the October 31st total of 1,600 shares. Currently, 0.5% of the company’s shares are short sold. Based on an average daily trading volume, of 29,300 shares, the short-interest ratio is currently 0.2 days.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on RedHill Biopharma in a report on Saturday, August 24th. They issued a “hold” rating on the stock.

RedHill Biopharma Trading Up 0.6 %

Shares of RDHL stock traded up $0.05 during trading on Thursday, reaching $7.96. The company’s stock had a trading volume of 9,274 shares, compared to its average volume of 110,355. RedHill Biopharma has a 1-year low of $6.34 and a 1-year high of $82.00. The stock’s 50-day moving average price is $8.15 and its 200 day moving average price is $132.21.

RedHill Biopharma Company Profile

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex.